Literature DB >> 6381375

Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice.

J Y Niederkorn.   

Abstract

A series of investigations was employed to determine if metastases of intraocular melanomas could be induced by experimental manipulations. Syngeneic B16F10 melanoma cells transplanted intracamerally into C57BL/6 mice produced progressively growing intraocular tumors, yet formed only occasional pulmonary metastases. Neither enucleation nor mechanical manipulation of the melanoma-containing eye promoted a significant increase in the incidence of metastases. Likewise, immunologic impairment in the form of natural killer cell deficiency, T-lymphocyte deficiency, or gamma-irradiation-induced lymphopenia failed to produce spontaneous metastases in intraocular melanoma-bearing mice. However, enucleation in consort with immune impairment (T-cell deficiency) produced a sharp increase in the incidence and number of pulmonary metastases in intraocular melanoma-bearing mice. Further studies showed that external pressure to the tumor-containing globe (without enucleation) produced extensive metastases in athymic, nude mice. By contrast, atraumatic enucleation of rapidly frozen eyes prevented metastasis of intraocular melanomas in similar hosts. Collectively, the results indicate that induction of distant metastases in hosts harboring intraocular melanomas requires two simultaneous processes: (1) mechanical manipulation of the melanoma-containing eye, and (2) concomitant impairment of T-cell-dependent immune processes. The data strongly suggest that mechanical manipulation of melanoma-containing eyes produces intravascular showers of melanoma cells that are rejected by T-cell-dependent immune processes in the immunocompetent host. In the absence of these normal T-cell-dependent immune mechanisms, enucleation-induced showers of blood-borne melanoma cells gain a foothold in the lung and form progressive metastases.

Entities:  

Mesh:

Year:  1984        PMID: 6381375

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice.

Authors:  G E Sanborn; J Y Niederkorn; J W Gamel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma.

Authors:  H E Grossniklaus
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 3.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

4.  Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine.

Authors:  G Sanborn; J Niederkorn; J Kan-Mitchell; D Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Low thyroid hormone levels improve survival in murine model for ocular melanoma.

Authors:  Ido Didi Fabian; Mordechai Rosner; Ina Fabian; Vicktoria Vishnevskia-Dai; Ofira Zloto; Elena Shinderman Maman; Keren Cohen; Martin Ellis; Hung-Yun Lin; Aleck Hercbergs; Paul J Davis; Osnat Ashur-Fabian
Journal:  Oncotarget       Date:  2015-05-10

6.  Animal Models of Uveal Melanoma.

Authors:  Ogul E Uner; Nikhila Gandrakota; Corrina P Azarcon; Hans E Grossniklaus
Journal:  Ann Eye Sci       Date:  2022-03-15

7.  The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.

Authors:  Emi Inagaki; Eri Arai; Shin Hatou; Tomoko Sayano; Hiroko Taniguchi; Kazuno Negishi; Yae Kanai; Yasunori Sato; Hideyuki Okano; Kazuo Tsubota; Shigeto Shimmura
Journal:  Stem Cells Transl Med       Date:  2022-08-23       Impact factor: 7.655

8.  The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.

Authors:  Hua Yang; Craig M Brackett; Vanessa Marie Morales-Tirado; Zezhong Li; Qing Zhang; Matthew W Wilson; Camille Benjamin; Wayne Harris; Edmund K Waller; Andrei V Gudkov; Lyudmila G Burdelya; Hans E Grossniklaus
Journal:  Oncotarget       Date:  2016-01-19

Review 9.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

Review 10.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.